| scholarly article | Q13442814 |
| P2093 | author name string | J. W. Pollard | |
| R. Kucherlapati | |||
| N. Yu | |||
| K. Lau | |||
| W. Edelmann | |||
| R. Kolodner | |||
| M. Lipkin | |||
| K. Fan | |||
| K. Yang | |||
| A. Umar | |||
| J. Heyer | |||
| T. Kunkel | |||
| G. F. Crouse | |||
| J. R. Lipford | |||
| M. F. Kane | |||
| P. E. Cohen | |||
| W. Liedtke | |||
| P2860 | cites work | Mutations of two PMS homologues in hereditary nonpolyposis colon cancer | Q24318484 |
| Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair | Q24318892 | ||
| Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients | Q57570041 | ||
| Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer | Q58862199 | ||
| Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability | Q71081409 | ||
| Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients | Q72608543 | ||
| A genetic map of the mouse with 4,006 simple sequence length polymorphisms | Q72702943 | ||
| hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6 | Q24323176 | ||
| Binding of insertion/deletion DNA mismatches by the heterodimer of yeast mismatch repair proteins MSH2 and MSH3. | Q27934985 | ||
| Mutation of a mutL homolog in hereditary colon cancer | Q28114939 | ||
| The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer | Q28256988 | ||
| Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer | Q28257360 | ||
| Biochemistry and genetics of eukaryotic mismatch repair | Q28282377 | ||
| Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over | Q28282791 | ||
| Identification of mismatch repair genes and their role in the development of cancer | Q28288647 | ||
| Isolation of an hMSH2-p160 Heterodimer That Restores DNA Mismatch Repair to Tumor Cells | Q28292781 | ||
| GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells | Q28292790 | ||
| Mutations of GTBP in genetically unstable cells | Q28292802 | ||
| Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer | Q28294774 | ||
| Polymerase delta variants in RER colorectal tumours | Q28299236 | ||
| Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations | Q28299699 | ||
| MSH2 deficient mice are viable and susceptible to lymphoid tumours | Q28508486 | ||
| Meiotic pachytene arrest in MLH1-deficient mice | Q28510650 | ||
| hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA | Q28610839 | ||
| Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes | Q29547355 | ||
| Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair | Q29615027 | ||
| Mismatch repair in replication fidelity, genetic recombination, and cancer biology | Q29616483 | ||
| WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras | Q34049134 | ||
| Mice develop normally without the H1(0) linker histone | Q34126573 | ||
| Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs | Q34554581 | ||
| Mutator phenotypes in human colorectal carcinoma cell lines | Q35568305 | ||
| Mechanisms and biological effects of mismatch repair | Q37041860 | ||
| APC mutations in colorectal tumors with mismatch repair deficiency | Q37383704 | ||
| Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis | Q38293261 | ||
| Differences in the spectrum of spontaneous mutations in the hprt gene between tumor cells of the microsatellite mutator phenotype | Q38358374 | ||
| Microsatellite instability in yeast: dependence on repeat unit size and DNA mismatch repair genes | Q40022200 | ||
| Mismatch repair and cancer susceptibility | Q40535755 | ||
| A hPMS2 mutant cell line is defective in strand-specific mismatch repair | Q41313494 | ||
| Mismatch Repair Deficiency in Phenotypically Normal Human Cells | Q41347026 | ||
| DNA loop repair by human cell extracts | Q41429743 | ||
| MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast | Q42427955 | ||
| Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
| Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation | Q46049171 | ||
| cDNA sequence, map, and expression of the murine homolog of GTBP, a DNA mismatch repair gene. | Q48060657 | ||
| Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer | Q48084125 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA mismatch repair | Q2984243 |
| MutS homolog 6 | Q14911719 | ||
| P304 | page(s) | 467–477 | |
| P577 | publication date | 1997-11-14 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Mutation in the mismatch repair gene Msh6 causes cancer susceptibility | |
| P478 | volume | 91 |
| Q27308400 | A MutSβ-Dependent Contribution of MutSα to Repeat Expansions in Fragile X Premutation Mice? |
| Q28272700 | A panoply of errors: polymerase proofreading domain mutations in cancer |
| Q36540457 | A personal historical view of DNA mismatch repair with an emphasis on eukaryotic DNA mismatch repair |
| Q36211150 | A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation |
| Q73916772 | ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL |
| Q41870415 | AID recruits UNG and Msh2 to Ig switch regions dependent upon the AID C terminus [corrected]. |
| Q36570190 | Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins |
| Q37001985 | Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells |
| Q33620910 | An ATM homologue from Arabidopsis thaliana: complete genomic organisation and expression analysis. |
| Q79832402 | An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation |
| Q36160898 | An unusual case of Turcot's syndrome associated with ileal adenocarcinoma, intestinal non-Hodgkin's lymphoma, and duodenal adenocarcinoma. Review of the classification and genetic basis of Turcot's syndrome |
| Q37108779 | Association of MSH6 mutation with glioma susceptibility, drug resistance and progression |
| Q58408696 | Association of a Duodenal Follicular Lymphoma and Hereditary Nonpolyposis Colorectal Cancer |
| Q24539206 | Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. |
| Q38320783 | Biochemical characterization of the interaction between the Saccharomyces cerevisiae MSH2-MSH6 complex and mispaired bases in DNA. |
| Q36761745 | Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms |
| Q42232513 | CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival |
| Q43678714 | Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities |
| Q28584954 | Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae |
| Q24302011 | Characterization of human exonuclease 1 in complex with mismatch repair proteins, subcellular localization and association with PCNA |
| Q35029027 | Chemoprevention of colorectal cancer: problems, progress, and prospects |
| Q35694485 | Chlorinated Water Modulates the Development of Colorectal Tumors with Chromosomal Instability and Gut Microbiota in Apc-Deficient Mice |
| Q58006247 | Clinical Definition of Hereditary Non-polyposis Colorectal Cancer: A Search for the Impossible? |
| Q34099201 | Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients |
| Q33875090 | Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing |
| Q26795724 | Colorectal cancer models for novel drug discovery |
| Q92645601 | Comparison of microsatellite status detection methods in colorectal carcinoma |
| Q34705149 | Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer |
| Q50647275 | Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice. |
| Q43706411 | Conditional inactivation of MLH1 in thymic and naive T-cells in mice leads to a limited incidence of lymphoblastic T-cell lymphomas |
| Q64388100 | DNA Breaks in Ig V Regions Are Predominantly Single Stranded and Are Generated by UNG and MSH6 DNA Repair Pathways |
| Q40513970 | DNA methyltransferase Dnmt1 and mismatch repair |
| Q39674490 | DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair |
| Q34164892 | DNA mismatch repair and cancer |
| Q74701340 | DNA mismatch repair and cancer |
| Q34814254 | DNA mismatch repair and infertility |
| Q24647002 | DNA mismatch repair: molecular mechanism, cancer, and ageing |
| Q35062449 | DNA repair defects in colon cancer |
| Q37083718 | DNA repair dysfunction in gastrointestinal tract cancers |
| Q37125781 | DNA repair genes are selectively mutated in diffuse large B cell lymphomas |
| Q28305177 | DNA replication error-induced extinction of diploid yeast |
| Q36487307 | DNA-damage repair; the good, the bad, and the ugly |
| Q74754539 | Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. Version 2 |
| Q33938090 | Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. Version 4. |
| Q74669209 | Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage: version 3 |
| Q37328459 | Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice. |
| Q51039462 | Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors. |
| Q43558008 | Differences in susceptibility to colonic stem cell somatic mutation in three strains of mice |
| Q46881522 | Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients |
| Q28592891 | Different mutator phenotypes in Mlh1- versus Pms2-deficient mice |
| Q22242924 | Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6 |
| Q35462738 | EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer |
| Q36646666 | Early and multiple origins of metastatic lineages within primary tumors |
| Q28592033 | Elevated mutant frequencies and increased C : G-->T : A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells |
| Q28592464 | Elevated mutant frequencies and predominance of G:C to A:T transition mutations in Msh6(-/-) small intestinal epithelium |
| Q37438949 | Epigenetic Enhancement of the Post-replicative DNA Mismatch Repair of Mammalian Genomes by a Hemi-(m)CpG-Np95-Dnmt1 Axis |
| Q37357503 | Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer |
| Q27939116 | Eukaryotic DNA mismatch repair |
| Q77753605 | Eukaryotic mismatch repair: an update |
| Q36896145 | Evaluation of a new panel of six mononucleotide repeat markers for the detection of DNA mismatch repair-deficient tumours |
| Q28589828 | Examination of Msh6- and Msh3-deficient mice in class switching reveals overlapping and distinct roles of MutS homologues in antibody diversification |
| Q30453984 | Extracolonic manifestations of lynch syndrome |
| Q34615262 | Frequent germline mutations and somatic repeat instability in DNA mismatch-repair-deficient Caenorhabditis elegans |
| Q35069957 | Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein |
| Q37821995 | GI GEMs: genetically engineered mouse models of gastrointestinal disease |
| Q33771627 | Genetic and Chemical Models of Colorectal Cancer in Mice |
| Q38111773 | Genomic instability and colon carcinogenesis: from the perspective of genes |
| Q47651868 | Genomic instability--the engine of tumorigenesis? |
| Q34547820 | HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1. |
| Q28589491 | HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions |
| Q37939634 | Haploinsufficiency in mouse models of DNA repair deficiency: modifiers of penetrance |
| Q35597944 | Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer |
| Q31119964 | Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain |
| Q30951743 | Identification of key transcription factors in caerulein-induced pancreatitis through expression profiling data |
| Q39514722 | Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry |
| Q36734614 | Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing |
| Q37115245 | Improvement of ENU Mutagenesis Efficiency Using Serial Injection and Mismatch Repair Deficiency Mice |
| Q34155290 | In vivo and in vitro studies of immunoglobulin gene somatic hypermutation |
| Q33755092 | Incomplete Segregation of MSH6 Frameshift Variants with Phenotype of Lynch Syndrome |
| Q49452061 | Inflammation-associated microsatellite alterations: Mechanisms and significance in the prognosis of patients with colorectal cancer |
| Q33643327 | Insights into cancer from transgenic mouse models |
| Q24553992 | Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin |
| Q33609937 | Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes |
| Q77537643 | Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation |
| Q28610863 | Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha |
| Q36821495 | LNA modification of single-stranded DNA oligonucleotides allows subtle gene modification in mismatch-repair-proficient cells |
| Q46640847 | Lack of DNA mismatch repair protein MSH6 in the rat results in hereditary non-polyposis colorectal cancer-like tumorigenesis |
| Q36259687 | Lynch syndrome (hereditary non-polyposis colorectal cancer): current concepts and approaches to management |
| Q36246487 | Lynch syndrome genes |
| Q22010995 | MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability |
| Q62068013 | MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir–Torre syndrome |
| Q27324793 | MSH2/MSH6 complex promotes error-free repair of AID-induced dU:G mispairs as well as error-prone hypermutation of A:T sites |
| Q28295022 | Mammalian MutS homologue 5 is required for chromosome pairing in meiosis |
| Q26740310 | Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer |
| Q34661270 | Maximizing mouse cancer models |
| Q28262719 | Mechanisms and functions of DNA mismatch repair |
| Q73311211 | Mediating mismatch repair |
| Q24627393 | Microsatellite instability in colorectal cancer |
| Q33756019 | Mismatch repair and immunoglobulin gene hypermutation: did we learn something? |
| Q33885063 | Mismatch repair defects in cancer |
| Q28219035 | Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking |
| Q42837072 | Mismatch repair proteins and AID activity are required for the dominant negative function of C-terminally deleted AID in class switching |
| Q28588324 | Mlh1 deficiency enhances several phenotypes of Apc(Min)/+ mice |
| Q26826949 | Modeling the study of DNA damage responses in mice |
| Q41005399 | Molecular events after antisense inhibition of hMSH2 in a HeLa cell line |
| Q25257401 | Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis |
| Q35433209 | Mononucleotide microsatellite instability and germline MSH6 mutation analysis in early onset colorectal cancer |
| Q35190411 | Mouse MutS-like protein Msh5 is required for proper chromosome synapsis in male and female meiosis |
| Q33739279 | Mouse models for colorectal cancer |
| Q28214396 | Mouse models for human DNA mismatch-repair gene defects |
| Q26774627 | Mouse models for the discovery of colorectal cancer driver genes |
| Q36583537 | Mouse models of DNA mismatch repair in cancer research |
| Q33579734 | Mouse models of colorectal cancer |
| Q92059453 | Mouse models of colorectal cancer: Past, present and future perspectives |
| Q34447472 | Mouse models of inherited cancer syndromes |
| Q81580735 | Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect |
| Q34254602 | Msh6 protects mature B cells from lymphoma by preserving genomic stability |
| Q24676755 | Muir-Torre-like syndrome in Fhit-deficient mice |
| Q46959635 | Murine mentors: transgenic and knockout models of surgical disease |
| Q33640905 | Murine models of colorectal cancer |
| Q24606421 | MutS homolog 4 localization to meiotic chromosomes is required for chromosome pairing during meiosis in male and female mice |
| Q28506014 | Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts |
| Q51038828 | Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. |
| Q35019548 | Mutation theory of aging, assessed in transgenic mice and knockout mice. |
| Q55260080 | Mutational analyses of multiple target genes in histologically heterogeneous gastric cancer with microsatellite instability. |
| Q33774967 | Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity |
| Q44945729 | Mutational-reporter transgenes rescued from mice lacking either Mgmt, or both Mgmt and Msh6 suggest that O6-alkylguanine-induced miscoding does not contribute to the spontaneous mutational spectrum |
| Q52828898 | Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines. |
| Q79198177 | Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer |
| Q36302118 | Mutsβ generates both expansions and contractions in a mouse model of the Fragile X-associated disorders |
| Q35742680 | Nbs1 ChIP-Seq Identifies Off-Target DNA Double-Strand Breaks Induced by AID in Activated Splenic B Cells |
| Q36150711 | Non-germline genetically engineered mouse models for translational cancer research |
| Q44294942 | Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice |
| Q77891937 | Notes from some crypt watchers: regulation of renewal in the mouse intestinal epithelium |
| Q41711225 | Novel dominant mutations in Saccharomyces cerevisiae MSH6. |
| Q33343446 | Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression. |
| Q37037194 | O6-methylguanine-induced cell death involves exonuclease 1 as well as DNA mismatch recognition in vivo |
| Q24644933 | Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs |
| Q33910331 | Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history |
| Q35576745 | Physical Activity and Cancer Prevention: Animal-Tumor Models |
| Q36547210 | Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis |
| Q48284592 | Potential mouse tumor model for pre-clinical testing of mage-specific breast cancer vaccines |
| Q37821231 | Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application. |
| Q34563112 | Proteasome activator PA200 is required for normal spermatogenesis |
| Q39464747 | Rapid DNA double-strand breaks resulting from processing of Cr-DNA cross-links by both MutS dimers |
| Q34646656 | Recent advances in cancer research: mouse models of tumorigenesis |
| Q34016965 | Repair of endogenous DNA base lesions modulate lifespan in mice |
| Q28258327 | Replicative DNA polymerase δ but not ε proofreads errors in Cis and in Trans |
| Q26766039 | Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs |
| Q34612512 | Requirement for Msh6, but not for Swi4 (Msh3), in Msh2-dependent repair of base-base mismatches and mononucleotide loops in Schizosaccharomyces pombe |
| Q34785026 | Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer |
| Q36779189 | Role of the mismatch repair gene, Msh6, in suppressing genome instability and radiation-induced mutations |
| Q33588064 | Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications. |
| Q33778759 | Selective induction of DNA repair pathways in human B cells activated by CD4+ T cells |
| Q35435690 | Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. |
| Q38314848 | Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer |
| Q73143600 | Signaling mismatch repair in cancer |
| Q45400063 | Simple detection of germline microsatellite instability for diagnosis of constitutional mismatch repair cancer syndrome |
| Q28510640 | Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern |
| Q36338216 | Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations |
| Q34272098 | Tailoring cancer vaccines to the elderly: the importance of suitable mouse models |
| Q28551589 | The Eukaryotic Mismatch Recognition Complexes Track with the Replisome during DNA Synthesis |
| Q37653026 | The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair |
| Q33901159 | The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation? |
| Q52671466 | The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability. |
| Q35647272 | The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer |
| Q47739281 | The genetics of hereditary common cancers |
| Q31833517 | The instability within: problems in current analyses of microsatellite instability |
| Q35037873 | The molecular and genetic basis of colon cancer |
| Q33890086 | Tumour suppressor gene mutations in humans and mice: parallels and contrasts |
| Q40384149 | U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma |
| Q35164207 | What role for AID: mutator, or assembler of the immunoglobulin mutasome? |
| Q40864619 | hMSH6 deficiency and inactivation of the alphaE-catenin invasion-suppressor gene in HCT-8 colon cancer cells. |
Search more.